Literature Citations
1. Development of Small-molecule Inhibitors of Fatty Acyl-AMP and Fatty Acyl-CoA Ligases in Mycobacterium tuberculosis. Baran, M., K.D. Grimes, P.A. Sibbald, P. Fu, H.I.M. Boshoff, D.J. Wilson, and C.C. Aldrich. European Journal of Medicinal Chemistry, 2020. 201: e112408. PMID[32574901]. PMCID[PMC7415619].
[PubMed]. TB_09_2020.
2. In Vitro Bactericidal Activity of 3-Cinnamoyl-4-hydroxy-6-methyl-2-pyrone (CHP) against Drug-susceptible, Drug-resistant and Drug-tolerant Isolates of Mycobacterium tuberculosis. Bhat, Z.S., M.A. Rather, H. Ul Lah, A. Hussain, M. Maqbool, S.K. Yousuf, Z. Jabeen, M.A. Wani, and Z. Ahmad. Journal of Global Antimicrobial Resistance, 2020. 22: p. 57-62. PMID[31809940].
[PubMed]. TB_09_2020.
3. Pentacyanoferrate(II) Complex of Pyridine-4- and Pyrazine-2-hydroxamic acid as Source of HNO: Investigation of Anti-tubercular and Vasodilation Activities. Carvalho, E.M., T. de Freitas Paulo, A.S. Saquet, B.L. Abbadi, F.S. Macchi, C.V. Bizarro, R. de Morais Campos, T.L.A. Ferreira, N.R.F. do Nascimento, L.G.F. Lopes, R. Chauvin, E.H.S. Sousa, and V. Bernardes-Génisson. Journal of Biological Inorganic Chemistry, 2020. 25(6): p. 887-901. PMID[32728907].
[PubMed]. TB_09_2020.
4. Graphene Oxide-linezolid Combination as Potential New Anti-tuberculosis Treatment. De Maio, F., V. Palmieri, G. Santarelli, G. Perini, A. Salustri, I. Palucci, M. Sali, J. Gervasoni, A. Primiano, G. Ciasca, M. Sanguinetti, M. De Spirito, G. Delogu, and M. Papi. Nanomaterials, 2020. 10(8): e1431. PMID[32707988]. PMCID[PMC7466666].
[PubMed]. TB_09_2020.
5. Synthesis and Biological Studies of Dodecameric Cationic Antimicrobial Peptides Containing Tetrahydrofuran amino acids. Ghosh, U., I. Soni, G. Kaul, P. Trivedi, V. Chaturvedi, S. Chopra, and T. Kanti Chakraborty. ChemBioChem, 2020. 21(17): p. 2518-2526. PMID[32297461].
[PubMed]. TB_09_2020.
6. 1,3-Disubstituted Urea Derivatives: Synthesis, Antimicrobial Activity Evaluation and in Silico Studies. Gündüz, M.G., S.B. Uğur, F. Güney, C. Özkul, V.S. Krishna, S. Kaya, D. Sriram, and D. Doğan Ş. Bioorganic Chemistry, 2020. 102: e104104. PMID[32736149].
[PubMed]. TB_09_2020.
7. Design, Synthesis and Biological Evaluation of Novel Triaryldimethylaminobutan-2-ol Derivatives against Mycobacterium tuberculosis. Liu, P., S. Fan, B. Wang, R. Cao, X. Wang, S. Li, Y. Lu, and W. Zhong. Bioorganic Chemistry, 2020. 102: e104054. PMID[32663665].
[PubMed]. TB_09_2020.
8. Use Chou's 5-Steps Rule to Evaluate Protective Efficacy Induced by Antigenic Proteins of Mycobacterium tuberculosis Encapsulated in Chitosan Nanoparticles. Pandey, R.P., S. Kumar, S. Ahmad, A. Vibhuti, V.S. Raj, A.K. Verma, P. Sharma, and E. Leal. Life Sciences, 2020. 256: e117961. PMID[32534039].
[PubMed]. TB_09_2020.
9. Synthesis and in Vitro Antitubercular Activity of Pyridine Analouges against the Resistant Mycobacterium tuberculosis. Patel, H., K. Chaudhari, P. Jain, and S. Surana. Bioorganic Chemistry, 2020. 102: e104099. PMID[32711084].
[PubMed]. TB_09_2020.
10. Structure-Activity Relationship of Natural and Synthetic Coumarin Derivatives against Mycobacterium tuberculosis. Pires, C.T., R.B. Scodro, D.A. Cortez, M.A. Brenzan, V.L. Siqueira, K.R. Caleffi-Ferracioli, L.C. Vieira, J.L. Monteiro, A.G. Corrêa, and R.F. Cardoso. Future Medicinal Chemistry, 2020. 12(17): p. 1533-1546. PMID[32820960].
[PubMed]. TB_09_2020.
11. Insight into Antimicrobial Activity of Substituted Phenylcarbamoyloxypiperazinylpropanols. Pospisilova, S., I. Malik, J. Curillova, H. Michnova, L. Cerna, T. Padrtova, J. Hosek, D. Pecher, A. Cizek, and J. Jampilek. Bioorganic Chemistry, 2020. 102: e104060. PMID[32663668].
[PubMed]. TB_09_2020.
12. Fragment-based Design of Mycobacterium tuberculosis InhA Inhibitors. Sabbah, M., V. Mendes, R.G. Vistal, D.M.G. Dias, M. Záhorszká, K. Mikušová, J. Korduláková, A.G. Coyne, T.L. Blundell, and C. Abell. Journal of Medicinal Chemistry, 2020. 63(9): p. 4749-4761. PMID[32240584]. PMCID[PMC7232676].
[PubMed]. TB_09_2020.
13. In Vitro Activity of a Novel Quinolone, UB-8902, against Ofloxacin-Resistant Mycobacterium tuberculosis Isolates. Tudó, G., A. Lopez-Gavin, E. Portell-Buj, J. Freixes, J. Vila, A. Roman, M.R. Monté, and J. Gonzalez-Martin. Microbial Drug Resistance, 2020. 26(9): p. 1019-1022. PMID[32159449].
[PubMed]. TB_09_2020.
14. Novel Isoniazid Derivative as Promising Antituberculosis Agent. Volynets, G.P., M.A. Tukalo, V.G. Bdzhola, N.M. Derkach, M.I. Gumeniuk, S.S. Tarnavskiy, and S.M. Yarmoluk. Future Microbiology, 2020. 15(10): p. 869-879. PMID[32662670].
[PubMed]. TB_09_2020.
15. Design, Synthesis and Antimycobacterial Activity of New Benzothiazinones Inspired by Rifampicin/Rifapentine. Wang, A., Y. Lu, K. Lv, C. Ma, S. Xu, B. Wang, A. Wang, G. Xia, and M. Liu. Bioorganic Chemistry, 2020. 102: e104135. PMID[32736151].
[PubMed]. TB_09_2020.
16. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents Based on Bedaquiline Structure. Wu, C., J. Luo, M. Wu, F. Meng, Z. Cai, Y. Chen, and T. Sun. Medicinal Chemistry, 2020. 16(5): p. 703-714. PMID[31203803].
[PubMed]. TB_09_2020.
17. Synthesis, Structural Characterization and Antitumor Activity of Six Rare Earth Metal Complexes with 8-Hydroxyquinoline Derivatives. Yang, Q.Y., Q.Q. Cao, Y.L. Zhang, X.F. Xu, C.X. Deng, R. Kumar, X.M. Zhu, X.J. Wang, H. Liang, and Z.F. Chen. Journal of Inorganic Biochemistry, 2020. 211: e111175. PMID[32858466].
[PubMed]. TB_09_2020.
Patent Citations
18. Benzimidazoles Derivatives as Anti-tuberculosis Agents. Shirude, P.S., M.R. Matnahalli, S. Narayanan, R.K. Shandil, and V. Potluri. Patent. 2020. 2020-IB52079 2020188405: 25pp.
[Patent]. TB_09_2020.